Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
Laura Z. Rassenti(University of California San Diego), Thomas J. Kipps(University of California San Diego), Donna Neuberg(Otsuka (Japan)), Feng He(Shanghai University of Traditional Chinese Medicine), Jennifer R. Brown(Dana-Farber Cancer Institute), Michael J. Keating(The University of Texas MD Anderson Cancer Center), Sonia Jain(University of Antwerp), Michael R. Grever(The Ohio State University Wexner Medical Center), John G. Gribben(Queen Mary University of London), William G. Wierda(The University of Texas MD Anderson Cancer Center), John C. Byrd(University of Cincinnati), Andrew Greaves(University of California San Diego), Neil E. Kay(Mayo Clinic)
Cited by 320
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k